Table 7.
Impact of LFD or HFD feeding on gene expression in cerebral hippocampus, hypothalamus and cortex after 1 or 3 weeks of feeding.
1 week | 3 weeks | ||||
---|---|---|---|---|---|
Gene | LFD | HFD | LFD | HFD | |
Hypothalamus | IL-1α* | 1.000 ± 0.161 | 0.955 ± 0.102 | 0.717 ± 0.151 | 0.865 ± 0.108 |
IL-1β* | 1.000 ± 0.239 | 1.005 ± 0.154 | 0.744 ± 0.201 | 0.729 ± 0.186 | |
IL-1R1* | 1.000 ± 0.143 | 0.915 ± 0.173 | 1.090 ± 0.189 | 1.420 ± 0.207 | |
1IL-1R2 | 1.000 ± 0.123 | 0.909 ± 0.185 | 1.101 ± 0.105 | 0.844 ± 0.215 | |
IL-1RA | 1.000 ± 0.288 | 0.894 ± 0.124 | 0.984 ± 0.209 | 1.235 ± 0.379 | |
TNF-α | 1.000 ± 0.207 | 0.901 ± 0.126 | 0.867 ± 0.109 | 0.928 ± 0.177 | |
IL-6# | 1.000 ± 0.114 | 0.942 ± 0.066 | 1.215 ± 0.071 | 0.963 ± 0.103 | |
CD45* | 1.000 ± 0.096 | 1.006 ± 0.028 | 0.892 ± 0.080 | 0.859 ± 0.094 | |
CD11b* | 1.000 ± 0.078 | 0.977 ± 0.045 | 0.832 ± 0.037 | 0.853 ± 0.065 | |
F4/80* | 1.000 ± 0.065 | 0.947 ± 0.062 | 0.793 ± 0.072 | 0.721 ± 0.057 | |
NGF* | 1.000 ± 0.081 | 1.006 ± 0.128 | 0.814 ± 0.070 | 0.839 ± 0.070 | |
BDNF* | 1.000 ± 0.115 | 1.088 ± 0.133 | 0.746 ± 0.124 | 0.649 ± 0.109 | |
Hypothalamus | IL-1α* | 1.000 ± 0.133 | 1.003 ± 0.114 | 0.743 ± 0.115 | 0.799 ± 0.106 |
IL-1β | 1.000 ± 0.274 | 0.946 ± 0.143 | 0.771 ± 0.207 | 0.979 ± 0.073 | |
1IL-1R2 | 1.000 ± 0.951 | 0.729 ± 0.119 | 0.609 ± 0.724 | 0.724 ± 0.471 | |
IL-1RA* | 1.000 ± 0.349 | 0.882 ± 0.249 | 0.632 ± 0.220 | 0.454 ± 0.125 | |
TNF-α* | 1.000 ± 0.172 | 0.835 ± 0.212 | 0.649 ± 0.205 | 0.710 ± 0.126 | |
1IL-6+ | 1.000 ± 0.123a | 1.054 ± 0.161a,b | 1.298 ± 0.069b | 0.923 ± 0.109a | |
CD45* | 1.000 ± 0.062 | 1.029 ± 0.072 | 0.850 ± 0.044 | 0.806 ± 0.049 | |
CD11b* | 1.000 ± 0.081 | 1.031 ± 0.085 | 0.913 ± 0.059 | 0.909 ± 0.095 | |
1F4/80* | 1.000 ± 0.043 | 0.957 ± 0.060 | 0.736 ± 0.095 | 0.659 ± 0.043 | |
NGF | 1.000 ± 0.216 | 0.768 ± 0.153 | 1.023 ± 0.288 | 0.800 ± 0.183 | |
BDNF | 1.000 ± 0.100 | 0.891 ± 0.124 | 0.876 ± 0.055 | 0.914 ± 0.087 | |
Cortex | IL-1α# | 1.000 ± 0.102 | 1.050 ± 0.069 | 0.844 ± 0.126 | 1.049 ± 0.084 |
1IL-1β | 1.000 ± 0.345 | 1.240 ± 0.077 | 1.083 ± 0.211 | 1.437 ± 0.131 | |
IL-1R1 | 1.000 ± 0.255 | 1.069 ± 0.116 | 0.868 ± 0.278 | 1.208 ± 0.201 | |
IL-1R2 | 1.000 ± 0.063 | 0.955 ± 0.064 | 0.976 ± 0.084 | 0.962 ± 0.103 | |
IL-1RA# | 1.000 ± 0.178 | 1.153 ± 0.104 | 0.935 ± 0.115 | 1.212 ± 0.146 | |
TNF-α | 1.000 ± 0.099 | 0.888 ± 0.104 | 0.903 ± 0.104 | 0.991 ± 0.150 | |
1IL-6 | 1.000 ± 0.139 | 1.042 ± 0.064 | 1.273 ± 0.120 | 1.068 ± 0.115 | |
1CD45 | 1.000 ± 0.071 | 1.115 ± 0.067 | 0.721 ± 0.629 | 1.069 ± 0.060 | |
CD11b | 1.000 ± 0.079 | 1.056 ± 0.073 | 0.981 ± 0.050 | 1.050 ± 0.075 | |
F4/80 | 1.000 ± 0.069 | 1.015 ± 0.071 | 0.960 ± 0.075 | 0.989 ± 0.076 | |
NGF* | 1.000 ± 0.067 | 0.884 ± 0.051 | 0.765 ± 0.053 | 0.761 ± 0.071 | |
BDNF+ | 1.000 ± 0.084a | 0.870 ± 0.037b | 0.830 ± 0.049b | 0.950 ± 0.063a |
Results are expressed as relative fold change in mRNA expression (mRNA), means ± SEM.; n = 6–8. Results within individual rows without a common superscript letter are significantly different.
P < 0.05, significant main effect of time.
P < 0.05, significant main effect of diet.
P < 0.05, significant time-diet interaction.
Friedman’s two-way ANOVA for non-parametric data used for analysis.